Federal Supply Schedule, FSS, 36F79721D0199
FDA Operator Number 10081154
Hot & Cold Therapy with One Device and 2 ounces of distilled water. Therapy for shoulder, back,
abdomen, hip, knee, elbow, ankle, occipital, eye, & head.
Special Veterans Administration Contract Pricing on
Government Contract FSS # V797D-50436
Range of Motion (ROM) Knee Brace
Brace & Cold Therapy: All-in-One
Combined with ThermaZone’s thermoelectric technology, the ROM Knee Brace provides stable knee support with consistent temperature distribution and management.
Other bone fillers take the form of pastes, putties, sponges and foams, all of which have major issues. Handling characteristics, mixing challenges, or simply
becoming a monolithic block are all compromises; none of which permit the easy movement of the patient’s fluids required to support living cells.
ReBossis is a unique new biosynthetic scaffold made of “tried and true” materials that have been successfully used in orthopedics for over 30 years. Poly Lactic-coglycolic acid, PLGA, silicate calcium carbonate and beta tri-calcium phosphate. The patents pertain to how OrthoReBirth USA uniquely combines the three by electro-spinning the formula into its distinctive “cotton like” form.
Titanium expanding PL-TL Device for sagittal balance and lodotic correction.
- PL approach with a 32mm or 40mm long device that articulates in the middle and deploys to form a ""V" / TL footprint.
- Lodosis is incremental from 0 degrees up to 15 degrees. (Adjacent chart shows angulation and height restoration.)
HiJAK AC, the first expandable Titanium cervical inter-body with ADJUSTABLE LORDOSIS, was designed for the surgeon who recognizes the importance of lordotic restoration and sagittal balance of the spine.
- Incremental expansion up to 7 degrees, 12 degrees, or Hyper-Lordotic 20 degrees dependent upon implant selection.
- An Osteo-Promotive Endplate Topography
- Post expansion graft packing capability
- An unobstructed graft chamber
New FDA Cleared Standalone HiJAK Cervical Device
"440innovations implanted the first device in the USA"
1.60mm Plate Height ~ 0-12 Degrees of Lodotic Adjustment ~ Proprietary Endplate Surface Technoloty
One Level Stand Alone With Lordotic Restoration ~ Adjacent Level Fixation Without Plate Removal
Kuros Biosciences (SIX:KURN) is focused on the development of innovative products for bone regeneration and is located in Schlieren (Zurich), Switzerland and Bilthoven, The Netherlands. Visit www.kurosbio.com for additional information on Kuros, its people, science and product pipeline.
Kuros Biosciences wins
2020 Spine Technology Award
Schlieren (Zurich), Switzerland, November 20, 2020 – Kuros Biosciences (SIX: KURN) today announced that it has won the 2020 Spine Technology Award, awarded by the widely-read industry publication Orthopedics This Week for outstanding innovations in the field, for its Fibrin-PTH (KUR-113) technology, which delivers targeted and controlled bone formation.
The prestigious award rounds off a year of strong progress for Kuros. Sales of lead product MagnetOs are accelerating, and the company has successfully initiated the STRUCTURE Phase 2 study with Fibrin-PTH, the first investigational trial of a drug biologic bone graft for spinal fusion. Fibrin-PTH targets a substantial clinical need in orthopedics and neurosurgery and addresses a significant unmet need.
The 2020 Spine Technology Award is the second prize won by Kuros this year, following an award in the Best Spinal Surgery Solutions Provider 2020 in GHP Magazine’s 2020 International Life Science Awards.
Joost de Bruijn, Chief Executive Officer of Kuros, said: “We are honored to have received the 2020 Spine Technology Award in recognition of Fibrin-PTH. Kuros has had an exciting year, with accelerating sales of MagnetOs and clinical progression of Fibrin-PTH. We look forward to continuing this progress in 2021 with a reinforced financial position following our upsized capital raise. I would like to thank Orthopedics This Week for their consideration of Kuros, which rewards the hard work and dedication of our employees and support of our investors.”
Fibrin-PTH (KUR-113) promotes bone formation through the induction of osteoprogenitor cell differentiation, enhancement of osteoblast proliferation and by increasing the lifespan of bone-forming cells.
Fibrin-PTH (KUR-113) is entering Phase 2 clinical trials for spine fusion in humans.
Fibrin-PTH (KUR-113) is the first ever investigational drug-biologic product candidate being evaluated for spinal fusion.
"Biphasic calcium phosphate with submicron surface topography in an Ovine model of instrumented posterolateral spinal fusion"
Lukas A. van Dijk, et.al., JOR Spine. 2018;e1039, Research Article, DIO: 10.1002/jsp2.1039 06November 2018
About the study:
MagnetOs Granules and MagnetOs Putty were implanted standalone and compared to autograft bone.
Twenty-five adult, female Merino sheep underwent posterolateral spinal fusion at L2-3 and L4-5 levels with instrumentation. After 6, 12, and 26 weeks, outcomes were evaluated by manual palpation, range of motion testing, micro-computed tomography, histology and histomorphometry. Fusion assessment by manual palpation 12 weeks after implantation revealed 100% fusion rates in all treatment groups. Similarly, the three treatment groups showed a statistically significant decrease in lateral bending at the fusion levels at 12 weeks and 26 weeks compared to the 6-week time-point, which further confirmed spinal fusion. No significant differences in range of motion were observed between the treatment groups at any of the time-points investigated.
Histological assessment at 12 weeks showed fusion rates of 75% for Autograft, 92% MagnetOs Granules, and 83% MagnetOs Putty.
The fusion rates were further increased 26 weeks post-implantation. Similar trends of bone growth were observed by histomorphometry.
(A) Porous BCP granule of 1-2 mm in size (B) submicron surface topography of epitaxial polygon crystals
Submersion in SBF resulted in the progressive formation of an apatite-like mineral layer on the material surface as shown by SEM after (C) 2 days, (D) 4 days, (E) 7 days, and (F) 10 days
Correspondence: Joost D. de Bruijn, School of Materials Science and Engineering, Queen Mary University of London, UK. Email: firstname.lastname@example.org
Aesculap Implant Systems
The only device with an anatomiclly designed S1 endplate.
activeL Artificial Disc
Intelligent Motion Technology
- The first lumbar artificial disc with a mobile ultra high molecular weight polyethylene core that can translate in the sagittal plane (anterior-posterior) up to 1.5 or 2.0mm, (based on device size) but does not translate laterally (four degrees of freedom).
Enhanced Longer-term Implant Stability Through Bone In-growth
- The bone-contacting surfaces of the endplates are coated with Plasmapore (Titanium) and a microscopic Calcium Phosphate over-coating, which provides an attractive surface due to a combination of pore size, porosity and roughness.
Widest Range of Footprints and Heights
- Range includes an 8.5 mm design, which is the lowest height construct available on the market.
Exclusive USA Distributor for Z-Medical
and GSA-FSS Contracted Product
Z-Medical GmbH + Co. KG
German Engineering provides Innovation, Precision, and Simplicity
MIS Z-Pedicle Screw
- One Tray of instruments
- Sterile packaging of implants
- Pre-assembled Set Screw (Set Screw inside Tower)
- The pre-Tower and Tulip are One Billet of Titanium, therefore surgeon may have direct manipulation of the screw without additional instruments
- Tower 12mm OD
- Rod reduction 40mm
- Self Drilling and Self Tapping Screws
- Fenestrated Screw Geometry (Saline or radiopaque dye may be injected with any applicator 260mm long and a tip diameter of 1.7mm to validate pedicle integrity)
- Specialty Screws for Spondylolisthesis, Fracture, and Deformity with 5 and 25 degrees of axial movement
For documents, special request, or distribution opportunities please send us an email. If you do not receive a response within 24 hours, please call to verify receipt.
Thanks for your inquiry,
Jim Talbert, Director
Post Office Box 12185, Newport News, Virginia 23612-2185